IMPORTANT STEMLINE THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit Has Been Filed in the Southern District of New York Against Stemline Therapeutics, Inc.
NEW YORK, Feb. 07, 2017 — Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York against Stemline Therapeutics, Inc. (“Stemline” or the “Company”) (NASDAQ:STML) on behalf of investors that acquired Stemline securities: (1) pursuant and/or traceable to Stemline’s secondary public …